Latest news with #Tyrer-Cuzick
Yahoo
6 days ago
- Entertainment
- Yahoo
Olivia Munn and John Mulaney Are 'Still Talking' About Whether They'll Use Their Last Frozen Embryo: 'Two Is a Lot' (Exclusive)
Olivia Munn says she and husband John Mulaney still have the option to pursue having another daughter "if we want," as they have one remaining viable frozen female embryo The embryo is from when Munn did IVF and an egg retrieval amid her breast cancer treatment to welcome their daughter Méi, 8 months Munn and Mulaney are also parents to son Malcolm, 3Olivia Munn and John Mulaney are still figuring out if they want to expand their full house. At the moment, the actress, 44, and the comedian, 42, are busy with two bustling careers, two kids — their son Malcolm, 3, and daughter Méi, 8 months — and two dogs. "Two [kids] is a lot," Munn tells PEOPLE in this week's cover story, on newsstands Friday. "We're still talking if we are done growing our family." The Your Friends & Neighbors star says she and Mulaney still have the option to pursue having another daughter "if we want," as they have one remaining viable frozen female embryo from when she did IVF and an egg retrieval following her breast cancer diagnosis in April 2023. They welcomed Méi via surrogate in September. After a clear mammogram and testing negative for the BRCA cancer gene, Munn was diagnosed only after an MRI — which her ob-gyn ordered after determining she was high-risk for breast cancer using the free online Tyrer-Cuzick risk assessment tool — discovered a spot in her right breast. After a lymph node dissection, a nipple delay procedure and a double mastectomy, Munn had 'a window' where she could do the egg retrieval before being sent into surgical menopause from having her uterus, fallopian tubes and ovaries removed in a hysterectomy with oophorectomy. 'It was important to do it at that moment, but it was also scary because my type of cancer feeds on hormones, and there are a lot of hormone injections with IVF,' says Munn, who later had reconstructive surgery. Munn's doctor put her on a special IVF protocol for cancer patients and was able to retrieve seven eggs (at Munn's age, about one in 10 eggs is healthy). After the eggs were fertilized, two of the embryos were 'strong enough to be tested for abnormalities and the gender,' says Munn, whose heart, along with Mulaney's, was set on a baby girl. "I remember I was on a walk with John, and I said, 'I really don't think that I'll be okay unless we get two girl embryos. I know this puts me at risk, but I just need you to support me,'" Munn recalls. "He said, 'Whatever you need.'" That same day, Munn's doctor called and told her they had two healthy female embryos. "That was a sign for me everything was going to be okay,' says Munn. Then began the process of finding a surrogate. A friend of a friend recommended an agency, and they gave her two profiles for potential surrogates. One of the women mentioned she wanted to help someone who had gone through cancer, and after meeting with her, Munn knew she was the right person to carry their daughter. 'The first thing I worried about was if I would be able to find somebody who would love and take care of my daughter as much as I would,' she says. 'We were so lucky to find someone so kind who we bonded with so much.' Still, as Munn grew a connection with her surrogate, with whom she remains close, she grappled with other fears. 'I had a concern of 'Will my daughter know me?'" she remembers. After Méi's arrival, Munn's anxieties disappeared.'Méi would cry, and I was the only one who could get her to stop,' she says. 'I knew she knew me, and I knew her. She's got this stick-straight hair that I had when I was baby. I think because I wasn't able to carry her, I really needed to see myself in her. I see myself in her so much.' Munn — who is currently filming season 2 of Your Friends & Neighbors in New York — describes Méi as the "squishiest, happiest baby" who loves her big brother. "Anywhere he goes, she lights up and she follows him," Munn says. "He's teaching her how to talk. We have this great video of him telling her to say dada, and she says dada right back. It's amazing. I asked if he could teach her mama, but he said no." Two years after her cancer diagnosis, 'it's so crazy to think that I'm sitting here with two amazing babies,' says Munn. 'I'm just so happy and grateful, and I'm really proud of what I've been able to do. I didn't know how much strength I had inside me.' Your Friends and Neighbors is streaming now on Apple TV+. Read the original article on People
Yahoo
23-03-2025
- Health
- Yahoo
Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence
CANBERRA, Australia, March 24, 2025 /PRNewswire/ -- Volpara Health, a global leader in AI-powered breast health solutions and a subsidiary of Lunit, today announced two major milestones: Volpara density is now a validated input to the BOADICEA breast cancer risk model. A record of 21 independent abstracts featuring Lunit and Volpara solutions were presented at ECR 2025. Volpara density now integrated into BOADICEA breast cancer risk model Volpara volumetric breast density assessment is now a validated input to the newly released version of the BOADICEA breast cancer risk model. This marks a significant milestone, as Volpara density is now integrated into two different breast cancer risk models—Tyrer-Cuzick and BOADICEA, sometimes referred to as IBIS or CanRisk, respectively. Any Volpara customers can use their Volpara density information via CanRisk today. CanRisk is endorsed by international societies and guidelines for use in Australia, the EU, the UK, the US, and Canada. Studies have shown the use of Volpara density in BOADICEA to improve model accuracy compared to using BI-RADS density categories, enhancing breast cancer risk assessment capabilities for healthcare providers worldwide. A record-high 21 Lunit and Volpara research abstracts at ECR 2025 At the European Congress of Radiology (ECR) 2025, Lunit and Volpara's solutions were featured in a record-high 21 independent research abstracts. This milestone highlights the growing impact of AI-driven breast health solutions in the global radiology community, reinforcing Volpara's and Lunit's commitment to advancing cancer detection and patient care through innovation and scientific research. About Volpara Health Volpara Health is on a mission to save families from cancer with AI-powered software that helps healthcare providers better understand cancer risk, guide personalized care decisions, and recommend additional imaging and interventions. Used in over 3,500 facilities by more than 9,500 technologists worldwide. Volpara's software impacts nearly 18M patients, supports over 3.6M annual cancer risk assessments, and integrates seamlessly with electronic health records and imaging systems. Volpara helps radiologists quantify dense breast tissue with precision and technologists produce mammograms with optimal positioning, compression, and dose. Volpara software also streamlines operations to ease compliance and accreditation. Volpara, a Lunit company, is headquartered in Wellington, New Zealand, and has an office in Seattle. Volpara is the trusted partner of leading healthcare institutions globally. For more information, visit Volpara Media Contact: Andrew Thompson-YoungClarity Quest Andrew@ Logo - View original content: SOURCE Volpara Health
